Study on the internalization mechanism of the ZEBRA cell-penetrating peptide

Roberta Marchione, Lavinia Liguori, David Laurin, Jean-Luc Lenormand

Abstract


Cell-penetrating peptides (CPPs) represent a noninvasive method for delivering functional biomolecules into living cells. We have recently shown that the Epstein-Barr virus transcriptional factor ZEBRA contains a protein transduction domain, named Z9 or minimal domain (MD). Only few of currently identified CPPs including MD are able to rapidly cross the mammalian cell membrane without being entrapped into endosomal compartments, even when fused to cargo macromolecules. In this work, a series of MD deletion mutants has been engineered and their cellular uptake has been analyzed by confocal microscopy and FACS. We identified a domain MD11 (8 amino acids shorter than MD) able to enter mammalian cells via a mainly endocytosis-independent mechanism. All the other generated truncated forms exhibited reduced cellular uptake and penetrated into cells through endocytic mechanisms. These results have highlighted the role of the MD11 C-terminal region as essential for efficient cellular entry and endosomal escape  and open new perspectives for the use of this CPP as carrier for delivering biologically active macromolecules with therapeutic potential.


Keywords


ZEBRA; Cell-Penetrating Peptide; transduction domain; endocytosis; endosomal escape

References


Akashi K, Miyata H, Itoh H & Kinosita K Jr. 1996 Preparation of giant liposomes in physiological conditions and their characterization under an optical microscope. Biophys J 71 3242-3250

Derossi D, Joliot AH, Chassaing G & Prochiantz A 1994 The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269 10444-10450

Deshayes S, Gerbal-Chaloin S, Morris MC, Aldrian-Herrada G, Charnet P, Divita G & Heitz F 2004 On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids. BBA 1667 141-147

Eiriksdottir E, Mager I, Lehto T, El Andaloussi SH & Langel U 2010 Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates. Bioconjugate Chem 21 1662-1672

Elliott G & O'Hare P 1997 Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88 223-233

Elmquist A, Lindgren M, Bartfai T & Langel U 2001 VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res 269 237-244

Frankel AD & Pabo CO 1988 Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 1189-1193

Green M & Loewenstein PM 1988 Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55 1179-1188

Heitz F, Morris MC & Divita G 2009 Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics Br J Clin Pharmacol 157 195-206

Henriques ST & Castanho MA 2004 Consequences of nonlytic membrane perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic vesicles. Biochem 43 9716-9724

Hirose H, Takeuchi T, Osakada H, Pujals S, Katayama S, Nakase I, Kobayashi S, Haraguchi T & Futaki S 2012 Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells. Mol Ther 20 984-993

Hoyer J, Schatzschneider U, Schulz-Siegmund M & Neundorf I 2012 Dimerization of a cell-penetrating peptide leads to enhanced cellular uptake and drug delivery. Beilstein J Org Chem 8 1788-1797

Kyte J & Doolittle RF 1982 A simple method for displaying the hydropathic character of a protein. J Mol Biol 157 105-132

Langel U 2006, in: E.L.U. CRC Press/Taylor & Francis (Ed.) Handbook of Cell-Penetrating Peptides, Boca Raton, London, New York.

Lundin P, Johansson H, Guterstam P, Holm T, Hansen M, Langel U & El Andaloussi SH 2008 Distinct uptake routes of cell-penetrating peptide conjugates. Bioconjugate Chem 19 2535-2542

Madani F, Lindberg S, Langel U, Futaki S & Graslund A 2011 Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys 2011 414729

Marchione R, Daydé D, Lenormand JL & Cornet M 2014 ZEBRA cell-penetrating peptide as an efficient delivery system in Candida albicans. Biotechnol J 9 1088-1094

Marchione R, Laurin D, Liguori L, Leibovitch MP, Leibovitch SA & Lenormand JL 2015 MD11-mediated delivery of recombinant eIF3f induces melanoma and colorectal carcinoma cell death. Mol Ther Methods Clin Dev 2 14056

Milech N, Longville BA, Cunningham PT, Scobie MN, Bogdawa HM, Winslow S, Anastasas M, Connor T, Ong F, Stone SR, Kerfoot M, Heinrich T, Kroeger KM, Tan YF, Hoffmann K, Thomas WR, Watt PM & Hopkins RM 2015 GFP-complementation assay to detect functional CPP and protein delivery into living cells. Sci Rep 16 18329

Mitchell DJ, Kim DT, Steinman L, Fathman CG & Rothbard JB 2000 Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res 56 318-325

Palm-Apergi C, Lonn P & Dowdy SF 2012 Do cell-penetrating peptides actually "penetrate" cellular membranes? Mol Ther 20 695-697

Park HH, Sohn Y, Yeo JW, Park JH, Lee HJ, Ryu J, Rhee WJ & Park TH 2014 Dimerization of 30Kc19 protein in the presence of amphiphilic moiety and importance of Cys-57 during cell penetration. Biotechnol J 9 1582-1593

Petosa C, Morand P, Baudin F, Moulin M, Artero JB & Muller CW 2006 Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol Cell 21 565-572

Pooga M, Hallbrink M, Zorko M & Langel U 1998 Cell penetration by transportan. FASEB J 12 67-77

Rothe R & Lenormand JL 2008 Expression and purification of ZEBRA fusion proteins and applications for the delivery of macromolecules into mammalian cells. Curr Protoc Protein Sci 18 18.11

Rothe R, Liguori L, Villegas-Mendez A, Marques B, Grunwald D, Drouet E & Lenormand JL 2010 Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator. J Biol Chem 285 20224-20233

Säälik P, Elmquist A, Hansen M, Padari K, Saar K, Viht K, Langel U & Pooga M 2004 Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjugate Chem 15 1246-1253

Säälik P, Niinep A, Pae J, Hansen M, Lubenets D, Langel Ü & Pooga M 2011 Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles. J Control Release 153 117-125

Simons K & Ikonen E 1997 Functional rafts in cell membranes. Nature 387 569-572

Terrone D, Sang SL, Roudaia L & Silvius JR 2003 Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential. Biochem 42 13787-13799

Ziegler A 2008 Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans. Adv Drug Deliv Rev 60 580-597

Zorko M & Langel U 2005 Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 57 529-545


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Copyright © 2018 Lorem Ipsum Press